OncoPharm cover image

NAPOLI 3, POUT, & Ivosidenib - Azole DDIs

OncoPharm

00:00

POUT disease‑free survival benefit

John summarizes POUT's 5‑year disease‑free survival improvement from 45% to 62% with adjuvant platinum‑gemcitabine.

Play episode from 10:05
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app